ALT Copy reads: “Early detection plays a crucial role in reducing cancer mortality, but meaningful progress requires collaboration across disciplines and institutions. ACED is driving this effort by bringing together leading experts to advance cutting-edge research and innovation. Through this collaborative approach, ACED aims to accelerate scientific breakthroughs, improve public health, and lessen the impact of cancer for people everywhere. Timothy Rebbeck, ACED Member Centre Director for Dana-Farber Cancer Institute." It also includes a photo of Timothy Rebbeck and the ACED partner logos: Cancer Research UK, Dana-Farber Cancer Institute, The University of Manchester, the German Cancer Research Center DKFZ, University College London, the Knight Cancer Institute and OHSU, and the University of Cambridge.

ALT Copy reads: “By fostering partnerships between institutions, researchers, policymakers, and patients, ACED can accelerate progress, standardize best practices, and ensure that early detection strategies are widely accessible. The involvement of various disciplines enhances our ability to address the scientific, medical, and societal challenges associated with early detection, ultimately benefiting patients worldwide. Michael Baumann, ACED Member Centre Director for the German Cancer Research Center (DKFZ).” It also includes a photo of Michael Baumann and the ACED partner logos: Cancer Research UK, Dana-Farber Cancer Institute, The University of Manchester, the German Cancer Research Center DKFZ, University College London, the Knight Cancer Institute and OHSU, and the University of Cambridge.